Global Home Infusion Therapy Market 2024-2028

Description

List of Tables

The home infusion therapy market is forecasted to grow by USD 17.37 bn during 2023-2028, accelerating at a CAGR of 8.12% during the forecast period. The report on the home infusion therapy market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by technological advancements in infusion pumps and remote monitoring devices, increasing prevalence of chronic diseases, and growing geriatric population worldwide requiring long-term medical care.

Market Scope
Base Year	2024
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	7.58%
CAGR	8.12%
Incremental Value	$17.37bn

Technavio's home infusion therapy market is segmented as below:

By Application

Anti-infective
Chemotherapy
Endocrinology
Enteral nutrition
Others

By Product

Infusion pumps
Needless connectors
Others

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increasing developments and collaborations for patient care and therapeutic options as one of the prime reasons driving the home infusion therapy market growth during the next few years. Also, expanding demand for specialty pharmacy services integrated with home infusion therapy offerings and rising initiations on specialized healthcare professionals for home infusion will lead to sizable demand in the market.

The report on the home infusion therapy market covers the following areas:

Home infusion therapy market sizing
Home infusion therapy market forecast
Home infusion therapy market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading home infusion therapy market vendors that include B.Braun SE, Baxter International Inc., Becton Dickinson and Co., Bio-Med Pvt. Ltd., Cardinal Health Inc., Catholic Health Initiatives, Community Surgical Supply, Fresenius SE and Co. KGaA, Health Vista Pvt Ltd., Health2home, ICU Medical Inc., Medix Infusion, Nipro Corp., Option Care Health Inc., Prochant, Reviv Genetics Ltd., Sober Care Surgical, UnitedHealth Group Inc., University of Pennsylvania Health System, and Walgreens Boots Alliance Inc.. Also, the home infusion therapy market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR77600

1 Executive Summary

1.1 Market overview

2 Market Landscape

2.1 Market ecosystem

3 Market Sizing

3.1 Market definition
3.2 Market segment analysis
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028

4 Historic Market Size

4.1 Global home infusion therapy market 2018 - 2022
4.2 Application Segment Analysis 2018 - 2022
4.3 Product Segment Analysis 2018 - 2022
4.4 Geography Segment Analysis 2018 - 2022
4.5 Country Segment Analysis 2018 - 2022

5 Five Forces Analysis

5.1 Five forces summary
5.2 Bargaining power of buyers
5.3 Bargaining power of suppliers
5.4 Threat of new entrants
5.5 Threat of substitutes
5.6 Threat of rivalry
5.7 Market condition

6 Market Segmentation by Application

6.1 Market segments
6.2 Comparison by Application
6.3 Anti-infective - Market size and forecast 2023-2028
6.4 Chemotherapy - Market size and forecast 2023-2028
6.5 Endocrinology - Market size and forecast 2023-2028
6.6 Enteral nutrition - Market size and forecast 2023-2028
6.7 Others - Market size and forecast 2023-2028
6.8 Market opportunity by Application

7 Market Segmentation by Product

7.1 Market segments
7.2 Comparison by Product
7.3 Infusion pumps - Market size and forecast 2023-2028
7.4 Needless connectors - Market size and forecast 2023-2028
7.5 Others - Market size and forecast 2023-2028
7.6 Market opportunity by Product

8 Customer Landscape

8.1 Customer landscape overview

9 Geographic Landscape

9.1 Geographic segmentation
9.2 Geographic comparison
9.3 North America - Market size and forecast 2023-2028
9.4 Europe - Market size and forecast 2023-2028
9.5 Asia - Market size and forecast 2023-2028
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
9.7 US - Market size and forecast 2023-2028
9.8 Germany - Market size and forecast 2023-2028
9.9 Japan - Market size and forecast 2023-2028
9.10 China - Market size and forecast 2023-2028
9.11 UK - Market size and forecast 2023-2028
9.12 Market opportunity By Geographical Landscape

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
11.3 Landscape disruption
11.4 Industry risks

12 Vendor Analysis

12.1 Vendors covered
12.2 Market positioning of vendors
12.3 B.Braun SE
12.4 Baxter International Inc.
12.5 Becton Dickinson and Co.
12.6 Bio-Med Pvt. Ltd.
12.7 Catholic Health Initiatives
12.8 Community Surgical Supply
12.9 Fresenius SE and Co. KGaA
12.10 Health Vista Pvt Ltd.
12.11 Health2home
12.12 ICU Medical Inc.
12.13 Option Care Health Inc.
12.14 Prochant
12.15 Reviv Genetics Ltd.
12.16 Sober Care Surgical
12.17 UnitedHealth Group Inc.

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
13.3 Currency conversion rates for US$
13.4 Research methodology
13.5 List of abbreviations